| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Departments of Ophthalmology and 2 Medicine and Therapeutics, University of Aberdeen, Aberdeen, Scotland, United Kingdom; and the 3 Division of Ophthalmology, University of Bristol, Bristol, United Kingdom.
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
METHODS. EAU was induced in Lewis rats, and a retina-derived macrophage-enriched population was generated by density centrifugation during the prepeak, peak, and resolution phases of the disease. Cell surface phenotype was assessed by two- and three-color flow cytometry, and function was determined in vitro by nitric oxide (NO) production, with or without further cytokine stimulation or by immunohistochemistry to determine expression of ß-glucuronidase, nitric oxide synthase (NOS)-2, and nitrotyrosine.
RESULTS. Myeloid-derived cells from normal retina were programmed similar to TGF-ß-stimulated uncommitted bone-marrow-derived macrophages (BMDMs). Contrary to BMDM behavior, retina-isolated macrophages displayed distinct properties and phenotype at different phases of the disease course and remained resistant throughout, to further cytokine challenge in vitro. During peak disease, retina-isolated macrophages had characteristics of IFN-
/TNF-
primed cells (nitrotyrosine positive and NO producing). Despite equivalent numbers of macrophages during resolution, their function reverted to characteristics of TGF-ß primed cells (ß-glucuronidase positive).
CONCLUSIONS. Resident retinal myeloid-derived cells are primed and are resistant to further cytokine stimulation, and, similar to macrophages derived during EAU recovery, behave operationally as though TGF-ß primed. During peak inflammation, infiltrating macrophages adapt to concurrent hierarchical Th1 T-cell response (IFN-/TNF-), generating NO. The results provide evidence of in vivo programming of macrophages within the retina.
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
activity.13
Thus, understanding and controlling macrophage function in inflammatory conditions such as EAU is of therapeutic importance. Macrophages are versatile cells that are intimately involved in all aspects of the immune response and the complex process of inflammation. Depending on the circumstances, macrophages increase the intensity of inflammation14 or promote its resolution.15 It has long been recognized that resident macrophages isolated from different anatomic sites are heterogeneous and that resident macrophages are adapted to the local microenvironment.16 17 Injury leads to a rapid increase in the number of macrophages in an inflamed or otherwise damaged tissue, and the infiltrating macrophages also adapt to the local microenvironment by the development of coordinated sets of properties that enable them to perform a particular function.18 Knowledge of what controls macrophage adaptation and dictates (or limits) the function that develops is essential for understanding how inflammation is regulated.
Macrophage functional development within an inflamed focus must be tightly regulated. It is unknown how that occurs, but in vitro studies suggest it is unlikely to be an aggregated response to all the stimuli to which they are exposed. We19 and others20 21 have shown that a number of pro- and anti-inflammatory cytokines influence macrophages toward development of sets of nonoverlapping and mutually exclusive properties or programs. Programming is determined by the first cytokine to which macrophages are exposed, and an essential component of the program is the development of unresponsiveness to other activating cytokines.19
Studies of glomerular macrophages isolated from normal and nephritic rats demonstrate the importance of macrophage programming in vivo.22
Glomerular macrophages from normal rats are uncommitted and can be activated in a variety of ways, whereas macrophages from glomeruli of rats with nephrotoxic nephritis behave operationally as though programmed by IFN-.22
Furthermore, TGF-ß3 infused into normal rats increases ß-glucuronidase expression by glomerular macrophages,23
which is identical with the response of bone-marrow-derived macrophages (BMDMs) to all TGF-ß isoforms in vitro.22
By contrast, glomerular macrophages from nephritic rats infused with TGF-ß3 did not increase ß-glucuronidase expression, which demonstrates that their usual activation pathway is dominant.23
These experiments suggest that high endogenous levels of TGF-ß3 may program resident tissue macrophages while failing to modulate the activities of macrophages infiltrating in response to immunologic injury. Whether similar macrophage function and responses are observed within an immunoregulatory environment, such as in either resident retinal myeloid populations or in infiltrating macrophages during retinal inflammation, is not known.24
Given that there is constitutive expression of TGF-ß (particularly TGF-ß2) within the eye25
and that retinal pigment epithelial cells can produce TGF-ß, studies of resident and infiltrating macrophages during an immune response in the retina are likely to provide important information on the mechanism responsible for macrophage activation and programming in vivo.
The purpose of this study was to examine macrophage functional development in the immune-privileged, TGF-ß-rich microenvironment of the eye during the evolution of inflammation in EAU. The results show that myeloid-derived cells from normal retina behave like BMDM that have been programmed by TGF-ß, whereas macrophages at peak disease have the characteristics of IFN--primed, TNF--activated macrophages, which shows that the immune regulatory effects of TGF-ß are overcome in the course of EAU. Resolution of inflammation is associated with restoration of macrophage properties to those found in resident retinal macrophages and BMDMs programmed by TGF-ß in vitro.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
was obtained from Bradsure Biologicals, Ltd. (Loughborough, UK) and human rTNF- and rTGF-ß1 were obtained from Sigma Chemical Co. (Dorset, UK). Rat rIL-4 was produced in-house, as described previously,26
using a CHO cell line generously donated by Neil Barclay (Medical Research Council [MRC] Cellular Immunology Unit, Oxford, UK). Soluble (s)TNF receptor (R)-IgG was kindly provided by and produced at the Therapeutic Antibody Centre, University of Oxford, as a chimeric molecule containing the soluble domain of the human p55 TNFR coupled to the CH2 and CH3 constant domains of human IgG1. Unless otherwise stated, mouse mAbs specific for rat cell surface markers (Table 1)
were obtained from Serotec (Oxford, UK), including mouse anti-rat I-A (OX6)-RPE and mouse anti-rat CD4 (w3/25). Purified anti-rat CD86 (B7-2), biotinylated mouse IgG1
(negative isotype control), biotinylated mouse anti-rat mononuclear phagocyte mAb (IC7), anti-rat CD11b/c (OX42), and streptavidin-AP complex (SA-APC) were obtained from PharMingen (San Diego, CA). Anti-mouse IgG (whole molecule) FITC conjugate was obtained from Sigma Chemical Co.
|
Immunization with bovine retinal antigens in the Lewis rat causes a self-limiting model of uveitis that, by convention, is segregated into three clinical phases. Prepeak injury starts 8 to 9 days after immunization and is characterized by a modest leukocyte infiltrate with little or no tissue injury. Leukocyte infiltration increases rapidly on about day 9 to 10 and is associated with photoreceptor destruction. This is the phase of peak injury, lasting for 2 to 3 days before injury subsides during the resolution phase. The cellular infiltrate is predominantly mononuclear, with infiltrates of macrophages and T cells within the retina, subretinal exudate, and vitreous.6
Isolation and Preparation of Macrophage Cultures
Animals were killed by CO2 asphyxiation from days 7 to 16 after immunization. The retinas of each animal were dissected microscopically in cold 1% BSA-PBS and then mechanically disrupted through a sieve (50 µm mesh) to obtain a single-cell suspension. Retinal cells of each animal were kept separate throughout isolation procedures. After further washes in 1% BSA-PBS, cells were subsequently isolated using a graduated gradient (Percoll density gradient; Pharmacia Upjohn, Uppsala, Sweden), as previously described,5
that enriches leukocytic populations within a mixed population of cells containing resident retinal cells, such as ganglion cells and neuronal elements. Cells were collected from the 1.072 and 1.088 g/mL layers and washed, and viability was determined by trypan blue exclusion (enriched retinal cell population). At this point 1 to 2 x 106 cells were separated for flow cytometric analysis (each animal was individually assessed). For culture, purity of CD11b/c+ macrophage cell numbers was confirmed by single-color flow cytometric analysis, and macrophage-enriched populations were plated at 5 x 105 CD11b/c+ macrophages per milliliter in 24-well tissue culture plates and rested for 1 hour at 37°C. RPMI complete medium was then replaced and the macrophages incubated for a further 24 hours, with or without cytokines. For analysis of normal and prepeak phases, animals were pooled to obtain adequate cell numbers for further analysis (between 4 and 6 retinas were required).
Uncommitted BMDMs were prepared as previously described19 and used in parallel in vitro assays as a positive control to confirm cytokine-mediated macrophage function. In brief, bone marrow cells were flushed aseptically from the dissected femurs of male Sprague-Dawley rats with complete medium through a 25-gauge needle to form a single-cell suspension. The cells were cultured in 75-mm tissue culture flasks and adhered to plastic in complete medium with L929-conditioned medium as a source of macrophage colony-stimulating factor (M-CSF). After 5 days in culture, macrophages were removed by using trypsin and recultured in 24-well plates at a concentration of 5 x 105 cells per well and rested overnight in M-CSF-free medium before being washed and stimulated (described later).
Assay culture conditions were optimized using BMDMs that had been cultured and stimulated as previously described.19
Cytokines used were IFN- (20 U/mL), TNF- (5 ng/mL), IL-4 (5 µL), and sTNFR-IgG (13 µg/mL), alone or administered sequentially in combination, each cytokine separated by a 4-hour period. Macrophage function was assessed 24 hours after first cytokine addition. IFN-, followed 4 hours later by TNF- (IFN/TNF), was used as a positive stimulation for NO production, confirming previous in vitro studies.19
Where stated, cytokine additions were made relative to IFN-/TNF- (positive control) stimulation. Cytokines were not removed before macrophage function was assessed.
Flow Cytometric Phenotypic Analysis of Retinal Macrophages
Immunophenotyping of infiltrating leukocytes was performed using mouse mAbs specific for the rat cell surface markers (listed later). mAbs used were either unconjugated or conjugated to biotin, PE, or FITC for three-color immunofluorescence. Unconjugated mAbs were detected with rat anti-mouse FITC, and biotinylated mAbs were detected with SA-APC. Staining was performed using flow cytometry buffer (PBS-BSA, 10 mM NaN3) for washes. All reagents, buffers, and incubations were kept and performed at 4°C. Negative isotype control and single positive control experiments were performed to allow accurate breakthrough compensation. Primary unconjugated mAbs included CD4, CD11b/c, and CD86. Cells were incubated sequentially with the primary mAb, anti-mouse IgG (whole molecule) FITC conjugate, in the presence of 10% normal rabbit serum (NRS), blocked with 10% normal mouse serum (NMS)-NRS, biotinylated second antibody (CD45, CD11b/c, or IC7) with PE-conjugated third antibody (mouse anti-I-A mouse/rat), and finally SA-APC. Acquisition was performed by flow cytometry (FACS Calibur; BD Bioscience, Plymouth, UK) and analysis with the accompanying software (CellQuest; BD Bioscience). A total of 10,000 events were collected, and gates and instrument settings were set according to forward- and side-scatter characteristics. Fluorescence analysis was performed after further back gating to exclude dead cells, the majority of neutrophils, and background staining.
Quantification of NO Synthesis
NO generation was estimated after 24 hours in culture by assaying culture supernatants for the stable reaction product of NO, nitrite, against a sodium nitrite standard on the same plate. Aliquots (200 µL) of each cell-free supernatant were incubated with 50 µL Griess reagent (0.5% sulfanilamide, 0.05% N-(1-naphtyl) ethylenediamine dihydrochloride in 2.5% phosphoric acid) in 96-well flat-bottomed plates for 10 minutes at room temperature. The optical densities were measured at 540 and 690 nm to account for background.
Parallel assays with control BMDMs typically produced the following amounts of NO: medium alone, 7.9 ± 0.8 µM; TGF-ß, 7.5 ± 0.7 µM; IFN-, 26.5 ± 2.1 µM; TNF-, 10.1 ± 0.9 µM; IFN-/TNF-, 30.6 ± 2.1 µM (Fig. 1a)
. The control findings illustrate the viability of the assay and permit comparison with stimulation profiles of retinal macrophages.
|
-naphthol AS-BI ß-D-glucuronide into the red soluble chromogenic naphthol AS-BI-horseradish peroxidase (HPR) complex.28
All components were obtained from Sigma Chemical Co. Cytospin preparations of macrophages harvested from culture or whole retinal cell populations were fixed in glutaraldehyde-acetone solution and the slides air dried. They were then stained with ß-glucuronidase staining solution and counterstained with methylene blue before being mounted in aqueous medium. BMDMs were stimulated, as described, to act as the control for cytokine conditioning and confirming previous data.19
Control BMDMs did not express ß-glucuronidase (Fig. 1b)
, whereas TGF-ß induced increased expression of ß-glucuronidase in cultured BMDMs (Fig. 1c)
.
Immunohistochemistry and Immunocytochemistry
Eyes removed from normal or immunized animals at the various stages of EAU were embedded in optimal cutting temperature (OCT) compound, snap frozen, and stored at -30°C. Serial 8-µm cryostat sections of the eyes were taken onto poly(L-lysine)-coated slides and air dried overnight. Cells were isolated from diseased eyes at various phases of disease and cytospins made with 
5 x 105 cells per slide. Before staining, tissue sections or cytospins were fixed in an acetone-methanol (1:1) mix at -20°C for 5 to 10 minutes and air dried. Sections were stained using either single or dual fluorescence for the following Abs: nitric oxide synthase (NOS)-2 (Clone 6, 1:100; Transduction Laboratories, Nottingham, UK) and infiltrating blood-borne macrophage marker ED1 (1:50, FITC conjugate; Serotec), and also through a standard avidin-biotin (alkaline phosphatase) technique for ED1 (1:100, purified, Serotec). The number of ED1-positive cells infiltrating throughout the retina and subretinal space, were counted throughout the section under a x20 objective. Three sections per eye were counted. Cytospins were stained through the same technique as was used for mouse monoclonal anti-nitrotyrosine (Clone 1A6, 1:20; Upstate Biotechnology, Lake Placid, NY). All washes and dilutions were in Tris-buffered saline (TBS), unless otherwise stated. For dual fluorescent staining, sections were blocked with NRS (1:5) for 20 minutes, followed by overnight incubation with anti-NOS-2 (1:100) at 4°C. After three 5-minute washes, a secondary biotinylated rabbit anti-mouse Ig (1:100, 10% NRS; Dako, Glostrup, Denmark) was added for 30 minutes, followed by further washes. Sections were then incubated with streptavidin-Texas red (1:50) for 30 minutes, washed, and incubated in ED1-FITC-conjugated mAb alone for 1 hour. Washed sections were then mounted (Vectashield; Vector Laboratories, Burlingame, CA) and viewed under the appropriate excitation filters of a microscope, according to the manufacturer’s instructions (BH2-RFC; Olympus, Tokyo, Japan).
Statistical Analysis
Differences between groups of NO production were analyzed by Kruskal-Wallis analysis of variance (ANOVA) and Dunnett posttest. Differences between groups for phenotypic analysis were analyzed by a one-way ANOVA and Tukey-Kramer posttest. All results are expressed as the mean ± SEM.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
|
Macrophage Function at Different Phases of EAU
NO generation by macrophages purified from uveitic eyes at different stages of the disease was chosen as a reliable indicator of macrophage programming by TGF-ß and IFN- in BMDMs and macrophages isolated from inflamed tissue.19
22
We ran parallel cultures of BMDMs with cytokine stimulation as the culture control for both IFN--mediated NO production and additionally TGF-ß-mediated ß-glucuronidase expression, thus allowing interpretation of retinal macrophage behavior. Macrophages isolated from normal retina (consisting of perivascular ED2+ macrophages and MG1
) generated little NO spontaneously (2.8 ± 0.6 µM; Fig. 3a
) and was not induced to do so by incubation with IFN- (Fig. 3a)
. This supports the hypothesis that TGF-ß, known to be present abundantly in the eye25
programs the resident macrophage population and renders the cells unresponsive to alternative activation by IFN-. These results are similar to those from resident glomerular macrophages from rats subjected to systemic administration of TGF-ß1,23
and contrast with those from normal rats that behave as though uncommitted and can be induced to generate NO by IFN-.19
|
and TNF- (data not shown). However, macrophages purified from uveitic eyes at peak disease (corresponding to maximum macrophage infiltration in the retina) spontaneously produced significant amounts of NO (9.0 ± 0.5 µM, P < 0.001; Fig. 3b
), and this production was not influenced by ex vivo incubation with the anti-inflammatory mediators IL-419
or sTNFR-IgG.
Because ED1 positivity remained high throughout the later stages of disease, we further divided the resolution phase into postpeak (days 13–15) and resolution (days 15–17 and onward), to dissect and assess kinetics of any change in macrophage function. During these phases, infiltrating retinal macrophages again produced little NO (3.9 ± 0.6 and 5.2 ± 0.5 µM, respectively) even after activation with IFN- and TNF- (Figs. 3c 3d)
.
In contrast to macrophages isolated from the postpeak phase, those isolated from peak phase did not express ß-glucuronidase (Fig. 4a)
. Thus, they behaved operationally as though activated by IFN-. A result identical with macrophages from inflamed glomeruli of rats at peak disease in nephrotoxic nephritis.22
This clearly demonstrates that the presumed immunoregulatory effects of TGF-ß are overcome in the posterior chamber of the eye during the course of EAU and that the macrophages infiltrating the retina are programmed by IFN-, known to be present in the retina at peak disease.4
30
Macrophages isolated from postpeak phase EAU expressed ß-glucuronidase; 21% showed strong ß-glucuronidase expression (Fig. 4b)
. However, by the resolution phase, this expression was absent (Fig. 4c)
. Such heterogeneity raises an important question: Either this is the first demonstration of macrophage reprogramming within an inflamed focus, or it is a reflection of the replacement of IFN- programmed peak disease macrophages by differentially activated macrophages infiltrating the retina during the resolution phase.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
and TNF-. Thus, inflammatory macrophages adapt to the local environment in a hierarchical way with the IFN- response predominating over that of TGF-ß at the height of EAU.
Resident retinal macrophages and those from the earliest phase of EAU generated little NO spontaneously, a characteristic feature of TGF-ß-conditioned BMDMs in vitro.19
They were also unable to generate NO in response to IFN- and TNF- in vitro—that is, they had been programmed not to respond to these cytokines. By contrast, macrophages from the height of disease spontaneously generated NO while displaying little ß-glucuronidase activity and were unable to increase expression in vitro—that is, they had programmed unresponsiveness to TGF-ß. These results are consistent with those in murine20
and rat19
BMDMs studied in vitro, in that prior exposure to TGF-ß abrogates responses to IFN-, whereas the IFN- response predominates when macrophages are stimulated with both cytokines at the same time. This is not simply the result of loss of cytokine receptors from the cell surface but reflects cross-talk between intracellular signaling pathways. For example, in some cell types,32
IFN- increases expression of the inhibitory Smad7 which abrogates TGF-ß signaling through the Smad pathway. Macrophages purified from eyes during the resolution phase of EAU again behaved as though conditioned by TGF-ß, presumably reflecting the reduction of proinflammatory stimuli at later stages. Regardless of the precise mechanisms involved, programming in vivo provided a mechanism for macrophages to promote repair after the need for them to cause tissue destruction had passed.
The large number of macrophages in the eye from the height of disease onward provides further evidence that macrophages have twin roles in injury and repair in uveitis, and this conclusion is supported by the changes that take place in the molecules they express on the cell surface. Roughly half the retinal macrophages purified from rats before peak injury reacted with the monoclonal antibody IC7, which recognizes an antigen found on mononuclear phagocytic cells of normal rats with a cellular distribution similar to CD68 and ED1.33 However in EAU the proportion of IC7-expressing macrophages decreased substantially throughout the course of the disease to 6% at the resolution phase, although it is worth noting that the greater number of retinal macrophages during this phase means that there were equivalent IC7-expressing retinal macrophages during both phases of the disease. Given that macrophages were predominantly ED1+ throughout the course of disease, the functional significance of IC7 expression remains undetermined. It is apparent that ED1+ cells can be either IC7+ or not at various phases of disease, and as we have shown herein, display varying activation profiles, implying that IC7 expression confers functional macrophage properties that differ from those conferred by ED1.
The change in the nature of the macrophages in the eye from prepeak disease to resolution was even more striking with regard to expression of CD4 and MHC class II. Both were expressed by roughly a quarter of macrophages from prepeak disease (by an average of 1000 macrophages per animal). By contrast, only 1% to 2% of macrophages at peak phase of disease expressed these markers, but the rapid increase in number of macrophages at this stage means that this fraction represents an almost identical number of positive macrophages. In other words, there was a substantial influx of CD4- and MHC class II-negative cells without reduction in the number of CD4- and MHC class II-positive cells. However, the absolute number of positive cells increased by about 10-fold during the resolution phase of disease. Whether the macrophages mature from CD4- and MHC class II-negative to CD4- and MHC class II-positive cells during the evolution of EAU or whether traffic of macrophages through the inflamed site means that negative cells are replaced by positive cells later in the course of the disease remains undetermined. Whatever the explanation, our data clearly show that the observed phenotypic differences in macrophages corresponding to changes in activation status had functional significance in vivo.
Classic and alternative macrophage activation has been proposed as a parallel to the Th1-Th2 paradigm.34
Classically, activated macrophages (effector macrophages) are characterized after exposure to IFN- and TNF- by their high NO production.19
However, macrophages, if conditioned by IL-10 or -4, have been proposed to downregulate inflammation and act to balance proinflammatory and anti-inflammatory immune reactions.35
Alternatively, activated macrophages exhibit broad specificity for foreign antigen and anti-inflammatory cytokines, as well as chemokines.36
We were able to confirm that resting-state resident macrophages, which are mainly MGs, exhibit responses corresponding to TGF-ß-mediated conditioning, in that macrophages were constitutively low NO producers (Fig. 2a)
. We chose NO generation as a measure of macrophage activation because, first, such functions have been used to characterize macrophage programming in vitro,19
and, second, the cytokines that induce such responses are present not only in normal retina but during EAU.37
Our results did not support evidence that once activated, macrophage function could be alternatively activated, despite previous in vitro studies that showed that macrophages can be reprogrammed when rested before alternative activation.18
For example, resident retinal macrophages including MGs displayed TGF-ß conditioning, with no increase in NO production after IFN-/TNF- stimulation, which was also observed in infiltrating macrophages during disease resolution. Because there was no correlation of the number of persistently nitrotyrosine-positive cells from peak to resolution and ß-glucuronidase-positive cells during the resolution phase, we have no evidence to support the notion that macrophages can change function in situ. To resolve this, we are currently investigating ex vivo macrophages in longer-term culture with respect to NOS-2 and ß-glucuronidase expression.
During peak and prepeak phases of disease, the dominant response in the rat is a Th1 IFN- response,38
and this corresponds with our findings that macrophages are activated, similar to BMDMs in vitro when stimulated with IFN-/TNF-. If TNF- activity is neutralized systemically through sTNFR-IgG, then retinal tissue damage is significantly reduced, despite continued infiltration of macrophages.13
Changes in phenotype have been shown during EAU, in that oxidative damage and peroxynitrite is principally restricted to the photoreceptors concomitant with ED1+/MHC class II+ mononuclear cell infiltration.31
In context with the present results, MHC class II and CD4 appear to be poor indicators of macrophages that cause tissue injury; we showed that during maximal NO production MHC class II expression was lowest, which is in keeping with reports that only NOS-2 relates directly to activation of macrophages to destroy tissue.39
The exact function of the MHC class II-positive macrophage remains to be determined. However, BMDMs, when stimulated through uptake of necrotic cells present antigen to T cells with greater efficiency and therefore may propagate or even initiate immune responses dependent on the signals they receive.40
In conclusion, therefore, our studies emphasize the distinct roles for macrophages at different stages during the evolution of EAU, and the potential importance for macrophage programming in determining which role they adopt. This regulation may permit the downregulation of macrophage function and allow, with the subsequent change in microenvironment during disease course, a new influx of macrophages to be alternatively programmed and provide different functions.
|
Footnotes |
|---|
Submitted for publication December 27, 2001; revised February 14, 2002; accepted March 1, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. 
1734 solely to indicate this fact.
Corresponding author: Andrew D. Dick, University of Bristol, Bristol Eye Hospital, Lower Maudlin Street, Bristol BS1 2LX, UK; a.dick{at}bristol.ac.uk.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-dependent mechanism J Immunol 159,5132-5142[Abstract]
This article has been cited by other articles:
|
|
 |
|
  J. Kezic, H. Xu, H. R. Chinnery, C. C. Murphy, and P. G. McMenamin Retinal Microglia and Uveal Tract Dendritic Cells and Macrophages Are Not CX3CR1 Dependent in Their Recruitment and Distribution in the Young Mouse Eye Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1599 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Copland, C. J. Calder, B. J.E. Raveney, L. B. Nicholson, J. Phillips, H. Cherwinski, M. Jenmalm, J. D. Sedgwick, and A. D. Dick Monoclonal Antibody-Mediated CD200 Receptor Signaling Suppresses Macrophage Activation and Tissue Damage in Experimental Autoimmune Uveoretinitis Am. J. Pathol., August 1, 2007; 171(2): 580 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. de Kozak, B. Omri, J. R. Smith, M.-C. Naud, B. Thillaye-Goldenberg, and P. Crisanti Protein Kinase C{zeta} (PKC{zeta}) Regulates Ocular Inflammation and Apoptosis in Endotoxin-Induced Uveitis (EIU): Signaling Molecules Involved in EIU Resolution by PKC{zeta} Inhibitor and Interleukin-13 Am. J. Pathol., April 1, 2007; 170(4): 1241 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Calder, L. B. Nicholson, and A. D. Dick A Selective Role for the TNF p55 Receptor in Autocrine Signaling following IFN-{gamma} Stimulation in Experimental Autoimmune Uveoretinitis J. Immunol., November 15, 2005; 175(10): 6286 - 6293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, A. Manivannan, R. Dawson, I. J. Crane, M. Mack, P. Sharp, and J. Liversidge Differentiation to the CCR2+ Inflammatory Phenotype In Vivo Is a Constitutive, Time-Limited Property of Blood Monocytes and Is Independent of Local Inflammatory Mediators J. Immunol., November 15, 2005; 175(10): 6915 - 6923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Wilson, S. Chettibi, C. Jobin, D. Walbaum, A. J. Rees, and D. C. Kluth Inhibition of Macrophage Nuclear Factor-{kappa}B Leads to a Dominant Anti-Inflammatory Phenotype that Attenuates Glomerular Inflammation in Vivo Am. J. Pathol., July 1, 2005; 167(1): 27 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Taylor, K. McConnachie, C. Calder, R. Dawson, A. Dick, J. D. Sedgwick, and J. Liversidge Enhanced Tolerance to Autoimmune Uveitis in CD200-Deficient Mice Correlates with a Pronounced Th2 Switch in Response to Antigen Challenge J. Immunol., January 1, 2005; 174(1): 143 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Gregerson, T. N. Sam, and S. W. McPherson The Antigen-Presenting Activity of Fresh, Adult Parenchymal Microglia and Perivascular Cells from Retina J. Immunol., June 1, 2004; 172(11): 6587 - 6597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. M. Minto, L.-P. Erwig, and A. J. Rees Heterogeneity of Macrophage Activation in Anti-Thy-1.1 Nephritis Am. J. Pathol., November 1, 2003; 163(5): 2033 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-P. Erwig, D. C. Kluth, and A. J. Rees Macrophage heterogeneity in renal inflammation Nephrol. Dial. Transplant., October 1, 2003; 18(10): 1962 - 1965. [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Sonoda, Y. Sasa, H. Qiao, C. Tsutsumi, T. Hisatomi, S. Komiyama, T. Kubota, T. Sakamoto, Y.-I. Kawano, and T. Ishibashi Immunoregulatory Role of Ocular Macrophages: The Macrophages Produce RANTES to Suppress Experimental Autoimmune Uveitis J. Immunol., September 1, 2003; 171(5): 2652 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Dick, D. Carter, M. Robertson, C. Broderick, E. Hughes, J. V. Forrester, and J. Liversidge Control of myeloid activity during retinal inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 161 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
